(function(){var loadHandler=window['sl_{EC00A760-FAC2-48CD-8603-FA3C7FB92E6B}'];loadHandler&&loadHandler(16, '<div id="spr0_3654301"><div id="spr1_3654301" class="kern slide"><img id="img0_3654301" src="data/img9.png" width="1280px" height="720px" alt="" style="left:0px;top:0px;"/></div><div id="spr2_3654301" class="kern slide"><div id="spr3_3654301" style="left:88px;top:38.333px;"><div style="width:0px;"><span id="txt0_3654301" data-width="839.838562" style="left:9.6px;top:24.307px;">National, regional and local stories?</span></div></div><div id="spr4_3654301" style="left:88px;top:191.667px;"><div style="width:0px;"><span id="txt1_3654301" class="nokern relpos" dir="auto" style="left:9.6px;top:-4.751px;">•</span> <span id="txt2_3654301" class="relpos" data-width="693.959656" style="left:21.463px;top:-9.634px;">Different decision makers have different needs – </span> <span id="txt3_3654301" class="relpos" data-width="327.454437" style="left:21.457px;top:-9.634px;">Reasons to challenge a</span></div><div style="width:0px;"><span id="txt4_3654301" data-width="235.269547" style="left:33.6px;top:19.486px;">successful story:</span></div><div style="width:0px;"><span id="txt5_3654301" class="nokern relpos" dir="auto" style="left:9.6px;top:108.507px;">•</span> <span id="txt6_3654301" class="relpos" data-width="342.807312" style="left:27.463px;top:103.623px;">Failure rate still too high</span></div><div style="width:0px;"><span id="txt7_3654301" class="nokern relpos" dir="auto" style="left:9.6px;top:150.96px;">•</span> <span id="txt8_3654301" class="relpos" data-width="477.987000" style="left:27.463px;top:146.076px;">Drugs with limited clinical efficacy</span></div><div style="width:0px;"><span id="txt9_3654301" class="nokern relpos" dir="auto" style="left:9.6px;top:193.413px;">•</span> <span id="txt10_3654301" class="relpos" data-width="914.350281" style="left:27.463px;top:188.53px;">Availability of multiple therapeutic options for some tumor types</span></div><div style="width:0px;"><span id="txt11_3654301" class="nokern relpos" dir="auto" style="left:9.6px;top:235.867px;">•</span> <span id="txt12_3654301" class="relpos" data-width="693.654968" style="left:27.463px;top:230.983px;">Financial burden of new drugs on Health Systems</span></div><div style="width:0px;"><span id="txt13_3654301" class="nokern relpos" dir="auto" style="left:9.6px;top:278.32px;">•</span> <span id="txt14_3654301" class="relpos" data-width="955.635437" style="left:27.463px;top:273.436px;">Segmentation of common cancers into diseases with rare molecular</span></div><div style="width:0px;"><span id="txt15_3654301" data-width="205.511719" style="left:39.6px;top:303.326px;">dysregulations</span></div><div style="width:0px;"><span id="txt16_3654301" class="nokern relpos" dir="auto" style="left:9.6px;top:349.893px;">•</span> <span id="txt17_3654301" class="relpos" data-width="674.307312" style="left:27.463px;top:345.01px;">The holy grail of personalised cancer medicine:</span></div><div style="width:0px;"><span id="txt18_3654301" data-width="994.567749" style="left:39.6px;top:374.899px;">the best drug for the «average» patient or the right drug for the right</span></div><div style="width:0px;"><span id="txt19_3654301" data-width="120.385422" style="left:39.6px;top:404.019px;">patient?</span></div></div><div id="spr5_3654301" style="left:424px;top:667.333px;"><div style="width:0px;"><span id="txt20_3654301" data-width="16.218750" style="left:207.833px;top:7.543px;">17</span></div></div></div></div>', '{"s":[]}');})();